Glen Iris, Australia

Paul Zientek


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Zientek: Innovator in Biomedical Materials

Introduction

Paul Zientek is a notable inventor based in Glen Iris, Australia. He has made significant contributions to the field of biomedical devices, particularly in the development of advanced composite materials. With a total of 2 patents to his name, Zientek's work focuses on enhancing the functionality and usability of ophthalmic devices.

Latest Patents

Zientek's latest patents revolve around multilayer materials designed for biomedical applications. One of his inventions is a composite material that features a hydrophilic coating, which is essential for creating ophthalmic devices such as contact lenses. This innovative material is characterized by its ability to hold a continuous layer of aqueous fluid on its wettable surfaces. The hydrophilic coating consists of a carbohydrate that is covalently attached to reactive groups on the surface of the bulk material. This invention not only improves the performance of contact lenses but also outlines a process for manufacturing such composite materials.

Career Highlights

Paul Zientek is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further explore and develop his innovative ideas in the field of biomedical materials. Zientek's contributions have been instrumental in advancing the technology behind ophthalmic devices, making them more effective and user-friendly.

Collaborations

Zientek has collaborated with several esteemed professionals in his field, including Ronald Christopher Chatelier and Liming Dai. These collaborations have enriched his research and development efforts, leading to groundbreaking advancements in biomedical technology.

Conclusion

Paul Zientek stands out as a prominent inventor in the realm of biomedical materials, with a focus on enhancing ophthalmic devices. His innovative patents and contributions to Novartis AG reflect his commitment to improving healthcare through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…